Bloodstream Infection Testing Market - Top Companies and Manufacturers

Companies Dominating the Bloodstream Infection Testing Landscape

The major players in the bloodstream infection testing market are offering a detailed portfolio of blood test-related products. These companies introduced advanced technologies that enable detailed visualization of blood test procedures.

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

biomerieux SA
Bruker Corporation
Danaher Corporation
DiaSorin S.p.A
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
T2 Biosystems, Inc.
Accelerate Diagnostics, Inc.
F. Hoffmann-La Roche Ltd

Browse Key Market Insights with Data Illustration:

Bloodstream Infection Testing Market Size, Growth Trends 2036

In the News

Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System) which is a breakthrough innovation for people who are suffering from chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The System is designed in such a way as to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.

Danaher Corporation launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild traumatic brain injury (TBI). Under this program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics which is a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of bloodstream infection testing was over USD 7 billion.

The market size for bloodstream infection testing is projected to cross USD 28 billion by the end of 2036 expanding at a CAGR of 9% during the forecast period i.e., between 2024-2036.

The major players in the market are Abbott Laboratories, biomerieux SA, Bruker Corporation, Danaher Corporation, DiaSorin S.p.A, Siemens Healthineers AG, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Accelerate Diagnostics, Inc., F. Hoffmann-La Roche Ltd, and others.

The reagents and consumables are anticipated to garner a share/size of 69% during 2024-2036.

The North America bloodstream infection sector is poised to hold 34% share by the end of 2036.

Bloodstream Infection Testing Market - Top Companies and Manufacturers

Companies Dominating the Bloodstream Infection Testing Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the bloodstream infection testing industry?

What is the outlook for the bloodstream infection testing market?

Who are the major players dominating the bloodstream infection testing landscape?

Which segment will capture the significant market share for bloodstream infection testing by 2036?

Which region will provide more opportunities for the bloodstream infection testing business in the near future?